RADX logo
Radiopharm Theranostics Limited(RADX)
$1.65—Stale · unknown old

Trailing Twelve Months (TTM) Metrics

Per Share (TTM)
Revenue/Share$0.24
Net Income/Share$-4.70
Operating CF/Share$-4.49
Free CF/Share$-1.93
Cash/Share$0.35
Book Value/Share$1.90
Tangible Book/Share$-1.35
Equity/Share$2.10
Interest Debt/Share$0.01
CapEx/Share$2.56
Dividend/Share$0.00
Valuation (TTM)
Market Cap$18.92M
Enterprise Value$14.78M
P/E Ratio-0.51P/S Ratio6.84
P/OCF Ratio-0.53
P/FCF Ratio-0.83
P/B Ratio1.14
P/TB Ratio1.14
EV/Sales5.34
EV/EBITDA-0.21
Graham Valuation
Graham Number--
Graham Net-Net$-1.75
Profitability (TTM)
Earnings Yield-195.68%FCF Yield-119.84%ROE-144.24%ROIC-158.08%Return on Tangible Assets-251.00%
Dividend (TTM)
Dividend Yield0.00%Payout Ratio0.00%
Capital Allocation
CapEx/OCF-57.05%
CapEx/Revenue1087.85%
CapEx/Depreciation22.23
SBC/Revenue0.00%
SG&A/Revenue585.85%
R&D/Revenue1920.52%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00
Debt/Market Cap0.00
Net Debt/EBITDA0.06
Current Ratio1.16Interest Coverage-626.93xIncome Quality0.96
Efficiency
Days Sales Outstanding2301 days
Days Payables Outstanding517 days
Days Inventory0 days
Receivables Turnover0.16x
Payables Turnover0.71x
Inventory Turnover0.00x
Capital Structure
Tangible Assets-$15.84M
Working Capital$3.03M
Invested Capital$41.24M
Intangibles/Assets63.46%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.